Dr. Menter on Neoadjuvant Immunotherapy in Early-Stage NSCLC

Developments in neoadjuvant immunotherapy options for early-stage lung cancer patientsПодробнее

Adjuvant Versus Neoadjuvant Therapy in NSCLCПодробнее

Dr. Donington on Neoadjuvant Immunotherapy in Lung CancerПодробнее

Drs. Altorki & Spicer discuss immunotherapy advances in stage I-III NSCLC: https://bit.ly/3HVzzoZПодробнее

Immunotherapy in Early Stage NSCLCПодробнее

Dr. Donington on the Role of Neoadjuvant Immunotherapy in Stage II NSCLCПодробнее

Updates in Early-Stage Lung Cancer: 2023 West OncologyПодробнее

Dr. Weksler on Neoadjuvant and Adjuvant Therapy in NSCLCПодробнее

Early intervention neoadjuvant immunotherapy in lung cancerПодробнее

Surgical perspective on neoadjuvant IO for resectable stage III NSCLCПодробнее

Clinical and translational results from the NEOSTAR study: treating early-stage lung cancer with...Подробнее

Dr. Spring on the Association Between pCR and Neoadjuvant ChemotherapyПодробнее

Dr. Nasser Altorki: Neoadjuvant immunotherapy and radiation boosts response in NSCLCПодробнее

Drs. Sepesi & Cascone discuss EGFR-targeted therapy in early-stage NSCLC: https://bit.ly/3oZllfoПодробнее

Adherence & outcomes of neoadjuvant immunotherapy in resectable NSCLCПодробнее

Multimodal Management of Early-Stage NSCLC: EGFR-Targeted Therapy in Perioperative SettingsПодробнее

Dr. Chaft on Investigational Neoadjuvant Immunotherapy Approaches in NSCLCПодробнее

Marking New Milestones With Immunotherapy in Locally Advanced and Early Lung CancerПодробнее

Immunotherapy for early-stage, resectable NSCLC: From clinical trial data to guidelinesПодробнее